Eli Lilly & Co. (LLY)
1009.52
-13.70
(-1.34%)
USD |
NYSE |
Feb 20, 16:00
1011.60
+2.08
(+0.21%)
After-Hours: 20:00
Eli Lilly SG&A Expense (Quarterly) : 3.132B for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.952B |
| Biogen, Inc. | 682.50M |
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Viking Therapeutics, Inc. | 11.28M |
| Moderna, Inc. | 308.00M |